- secretariat-intl.com
- 123
- 65
- 123
When our client, a biopharmaceutical company, had exclusively licensed a patent for a novel type of cancer immunotherapy, a competitor undertook substantial efforts to be first to market for its lead indication despite being aware of potential..
Relevance: 2.1896768